| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 31 | 2022 | 471 | 6.400 |
Why?
|
| Synapses | 21 | 2020 | 222 | 4.920 |
Why?
|
| Synaptic Transmission | 18 | 2021 | 236 | 3.290 |
Why?
|
| CA1 Region, Hippocampal | 9 | 2022 | 12 | 3.210 |
Why?
|
| Long-Term Potentiation | 16 | 2022 | 53 | 3.060 |
Why?
|
| Long-Term Synaptic Depression | 8 | 2017 | 32 | 2.930 |
Why?
|
| Estradiol | 7 | 2015 | 176 | 2.530 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 12 | 2018 | 266 | 2.530 |
Why?
|
| Neuronal Plasticity | 11 | 2022 | 274 | 2.340 |
Why?
|
| CA3 Region, Hippocampal | 4 | 2020 | 9 | 1.970 |
Why?
|
| Alzheimer Disease | 6 | 2022 | 565 | 1.790 |
Why?
|
| Rats, Sprague-Dawley | 26 | 2020 | 2083 | 1.560 |
Why?
|
| Dentate Gyrus | 3 | 2021 | 13 | 1.460 |
Why?
|
| Rats | 30 | 2022 | 5300 | 1.450 |
Why?
|
| Animals | 58 | 2022 | 20881 | 1.330 |
Why?
|
| Interneurons | 8 | 2019 | 70 | 1.280 |
Why?
|
| Ketamine | 2 | 2020 | 57 | 1.250 |
Why?
|
| Hyperoxia | 2 | 2018 | 27 | 1.200 |
Why?
|
| Antidepressive Agents | 2 | 2020 | 216 | 1.200 |
Why?
|
| Perforant Pathway | 2 | 2017 | 4 | 1.090 |
Why?
|
| Receptors, Muscarinic | 5 | 2019 | 44 | 1.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2015 | 175 | 1.050 |
Why?
|
| Aging | 4 | 2022 | 911 | 0.970 |
Why?
|
| Pyramidal Cells | 7 | 2021 | 79 | 0.970 |
Why?
|
| Neural Inhibition | 5 | 2020 | 80 | 0.930 |
Why?
|
| Fear | 3 | 2022 | 239 | 0.920 |
Why?
|
| Visual Cortex | 3 | 2010 | 67 | 0.910 |
Why?
|
| Memory | 3 | 2021 | 214 | 0.910 |
Why?
|
| Cholinergic Fibers | 2 | 2014 | 27 | 0.820 |
Why?
|
| Estrogens | 2 | 2015 | 173 | 0.810 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2021 | 115 | 0.810 |
Why?
|
| Receptors, AMPA | 3 | 2014 | 99 | 0.810 |
Why?
|
| Learning | 2 | 2021 | 186 | 0.800 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2022 | 28 | 0.780 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2020 | 284 | 0.770 |
Why?
|
| Neurons | 9 | 2021 | 881 | 0.760 |
Why?
|
| Neostriatum | 2 | 2020 | 60 | 0.760 |
Why?
|
| Dystonia | 2 | 2019 | 18 | 0.750 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2021 | 153 | 0.750 |
Why?
|
| Receptors, GABA-A | 2 | 2020 | 89 | 0.730 |
Why?
|
| Extinction, Psychological | 1 | 2022 | 240 | 0.720 |
Why?
|
| Molecular Chaperones | 2 | 2019 | 81 | 0.720 |
Why?
|
| Acetylglucosamine | 2 | 2017 | 46 | 0.710 |
Why?
|
| Action Potentials | 4 | 2018 | 223 | 0.700 |
Why?
|
| Excitatory Postsynaptic Potentials | 10 | 2021 | 87 | 0.680 |
Why?
|
| Receptor, Muscarinic M1 | 3 | 2010 | 17 | 0.660 |
Why?
|
| Sympathetic Fibers, Postganglionic | 2 | 2010 | 2 | 0.630 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2017 | 58 | 0.610 |
Why?
|
| Dendritic Spines | 4 | 2019 | 76 | 0.610 |
Why?
|
| Cognitive Dysfunction | 2 | 2020 | 176 | 0.600 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2019 | 109 | 0.600 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2016 | 18 | 0.600 |
Why?
|
| Parasympathetic Nervous System | 1 | 2017 | 14 | 0.590 |
Why?
|
| Tretinoin | 1 | 2017 | 92 | 0.560 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2014 | 38 | 0.560 |
Why?
|
| Vitamin A | 1 | 2017 | 111 | 0.540 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 2 | 2008 | 12 | 0.540 |
Why?
|
| Behavior, Animal | 3 | 2019 | 470 | 0.530 |
Why?
|
| Glycine | 3 | 2006 | 89 | 0.520 |
Why?
|
| In Vitro Techniques | 11 | 2017 | 765 | 0.510 |
Why?
|
| Proteins | 2 | 2018 | 474 | 0.510 |
Why?
|
| Fragile X Mental Retardation Protein | 2 | 2014 | 20 | 0.500 |
Why?
|
| Organ Culture Techniques | 7 | 2017 | 122 | 0.500 |
Why?
|
| Physostigmine | 1 | 2014 | 14 | 0.480 |
Why?
|
| Adrenergic Fibers | 2 | 2014 | 4 | 0.480 |
Why?
|
| Patch-Clamp Techniques | 10 | 2020 | 204 | 0.480 |
Why?
|
| Chloride Channels | 2 | 2005 | 22 | 0.470 |
Why?
|
| Acetylglucosaminidase | 1 | 2014 | 8 | 0.470 |
Why?
|
| Helplessness, Learned | 1 | 2014 | 9 | 0.470 |
Why?
|
| Depressive Disorder | 1 | 2018 | 621 | 0.460 |
Why?
|
| Ion Channel Gating | 3 | 2005 | 42 | 0.460 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 2550 | 0.450 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 2009 | 208 | 0.450 |
Why?
|
| Resilience, Psychological | 1 | 2014 | 43 | 0.450 |
Why?
|
| Epilepsy | 1 | 2017 | 336 | 0.440 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2014 | 116 | 0.440 |
Why?
|
| Form Perception | 1 | 2012 | 16 | 0.420 |
Why?
|
| Mice | 15 | 2022 | 8474 | 0.420 |
Why?
|
| Spatial Memory | 2 | 2022 | 9 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 2791 | 0.410 |
Why?
|
| Cognitive Aging | 2 | 2022 | 3 | 0.410 |
Why?
|
| Pattern Recognition, Visual | 1 | 2012 | 69 | 0.410 |
Why?
|
| Acetylcholine | 4 | 2019 | 64 | 0.380 |
Why?
|
| Male | 21 | 2022 | 37321 | 0.380 |
Why?
|
| Menopause | 1 | 2010 | 47 | 0.370 |
Why?
|
| Circadian Rhythm | 3 | 2022 | 218 | 0.360 |
Why?
|
| Ovariectomy | 3 | 2015 | 49 | 0.350 |
Why?
|
| Female | 16 | 2022 | 38074 | 0.350 |
Why?
|
| Glycosylation | 3 | 2020 | 185 | 0.350 |
Why?
|
| Rats, Transgenic | 2 | 2021 | 24 | 0.340 |
Why?
|
| Carbachol | 4 | 2008 | 34 | 0.340 |
Why?
|
| Sex Characteristics | 2 | 2022 | 295 | 0.330 |
Why?
|
| Strychnine | 3 | 2005 | 14 | 0.330 |
Why?
|
| Electric Stimulation | 6 | 2013 | 218 | 0.310 |
Why?
|
| Vision, Ocular | 1 | 2008 | 68 | 0.300 |
Why?
|
| Simvastatin | 3 | 2014 | 34 | 0.300 |
Why?
|
| Excitatory Amino Acid Antagonists | 4 | 2018 | 128 | 0.300 |
Why?
|
| tau Proteins | 2 | 2020 | 61 | 0.290 |
Why?
|
| GABA Antagonists | 4 | 2021 | 22 | 0.290 |
Why?
|
| Glutamic Acid | 3 | 2020 | 332 | 0.290 |
Why?
|
| Piperidines | 3 | 2014 | 123 | 0.280 |
Why?
|
| Animals, Newborn | 2 | 2018 | 396 | 0.280 |
Why?
|
| Choline | 1 | 2006 | 14 | 0.270 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 700 | 0.270 |
Why?
|
| Protein Kinase C | 1 | 2007 | 270 | 0.270 |
Why?
|
| Glycine Agents | 2 | 2002 | 5 | 0.270 |
Why?
|
| Nerve Regeneration | 1 | 2006 | 42 | 0.260 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2017 | 64 | 0.260 |
Why?
|
| Tissue Culture Techniques | 2 | 2015 | 62 | 0.250 |
Why?
|
| Phosphorylation | 4 | 2017 | 1200 | 0.250 |
Why?
|
| Cholinergic Agonists | 2 | 2008 | 5 | 0.240 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 1033 | 0.240 |
Why?
|
| Receptors, Nicotinic | 2 | 1994 | 41 | 0.230 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1293 | 0.220 |
Why?
|
| Receptors, Glycine | 1 | 2002 | 9 | 0.210 |
Why?
|
| Receptor, Muscarinic M3 | 2 | 2014 | 10 | 0.210 |
Why?
|
| Signal Transduction | 4 | 2018 | 2689 | 0.210 |
Why?
|
| Enzyme Inhibitors | 4 | 2017 | 659 | 0.210 |
Why?
|
| Chlorides | 1 | 2002 | 68 | 0.200 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2021 | 1 | 0.200 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 7 | 0.200 |
Why?
|
| Cognition | 2 | 2017 | 513 | 0.190 |
Why?
|
| Prodromal Symptoms | 1 | 2021 | 5 | 0.190 |
Why?
|
| Cerium | 1 | 2021 | 6 | 0.190 |
Why?
|
| Optogenetics | 1 | 2021 | 20 | 0.190 |
Why?
|
| Cytosol | 1 | 2021 | 123 | 0.190 |
Why?
|
| Time Factors | 5 | 2014 | 4655 | 0.190 |
Why?
|
| Corpus Striatum | 2 | 2020 | 279 | 0.190 |
Why?
|
| Locus Coeruleus | 1 | 2021 | 55 | 0.190 |
Why?
|
| Amygdala | 1 | 2022 | 159 | 0.180 |
Why?
|
| Age Factors | 3 | 2014 | 1864 | 0.180 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 134 | 0.180 |
Why?
|
| Oxidative Stress | 3 | 2021 | 718 | 0.180 |
Why?
|
| Receptors, GABA | 2 | 1997 | 8 | 0.180 |
Why?
|
| Maze Learning | 2 | 2019 | 138 | 0.180 |
Why?
|
| Protein Kinases | 1 | 2020 | 122 | 0.180 |
Why?
|
| Enzyme Activation | 3 | 2021 | 791 | 0.180 |
Why?
|
| Glucosamine 6-Phosphate N-Acetyltransferase | 1 | 2019 | 1 | 0.170 |
Why?
|
| Cholinergic Neurons | 1 | 2019 | 5 | 0.170 |
Why?
|
| Humans | 14 | 2021 | 68618 | 0.170 |
Why?
|
| Apolipoprotein E3 | 1 | 2019 | 7 | 0.170 |
Why?
|
| Phenols | 2 | 2012 | 73 | 0.170 |
Why?
|
| Ozone | 1 | 2019 | 13 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 194 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 214 | 0.160 |
Why?
|
| Extracellular Space | 2 | 2019 | 121 | 0.160 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 271 | 0.160 |
Why?
|
| Superior Cervical Ganglion | 2 | 2010 | 6 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 122 | 0.160 |
Why?
|
| Memory Disorders | 1 | 2019 | 111 | 0.150 |
Why?
|
| Rats, Inbred F344 | 1 | 2017 | 104 | 0.150 |
Why?
|
| Acylation | 2 | 2016 | 22 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2020 | 272 | 0.150 |
Why?
|
| Muscarinic Agonists | 2 | 2008 | 17 | 0.150 |
Why?
|
| Calcium Channels | 1 | 1997 | 59 | 0.150 |
Why?
|
| Models, Neurological | 3 | 2009 | 136 | 0.150 |
Why?
|
| Spatial Navigation | 1 | 2017 | 1 | 0.150 |
Why?
|
| Synaptophysin | 1 | 2017 | 16 | 0.150 |
Why?
|
| Period Circadian Proteins | 1 | 2017 | 16 | 0.150 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 35 | 0.150 |
Why?
|
| Environmental Exposure | 1 | 2019 | 269 | 0.140 |
Why?
|
| Computational Biology | 1 | 2018 | 190 | 0.140 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2016 | 10 | 0.140 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 2 | 2008 | 2 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 118 | 0.140 |
Why?
|
| Proestrus | 1 | 2015 | 1 | 0.130 |
Why?
|
| Membrane Potentials | 4 | 1998 | 200 | 0.130 |
Why?
|
| Anxiety | 1 | 2019 | 422 | 0.130 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2015 | 21 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 447 | 0.130 |
Why?
|
| Frontotemporal Dementia | 1 | 2014 | 17 | 0.120 |
Why?
|
| Temporal Lobe | 1 | 2015 | 125 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2014 | 34 | 0.120 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 1994 | 5 | 0.120 |
Why?
|
| Bicuculline | 1 | 1994 | 17 | 0.120 |
Why?
|
| Geniculate Bodies | 1 | 1994 | 10 | 0.120 |
Why?
|
| Muscarinic Antagonists | 1 | 2014 | 54 | 0.120 |
Why?
|
| Mesencephalon | 1 | 1994 | 41 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 44 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 134 | 0.120 |
Why?
|
| Nerve Endings | 1 | 1993 | 14 | 0.120 |
Why?
|
| Endorphins | 1 | 1993 | 32 | 0.120 |
Why?
|
| Protein Subunits | 1 | 2014 | 99 | 0.110 |
Why?
|
| Nerve Growth Factor | 1 | 2014 | 54 | 0.110 |
Why?
|
| Fragile X Syndrome | 1 | 2013 | 17 | 0.110 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 166 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2014 | 48 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 290 | 0.110 |
Why?
|
| Neural Pathways | 1 | 2015 | 324 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 99 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2673 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 212 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2014 | 525 | 0.100 |
Why?
|
| Entorhinal Cortex | 1 | 2012 | 11 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 191 | 0.100 |
Why?
|
| Prenylation | 1 | 2011 | 1 | 0.100 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2011 | 8 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 33 | 0.100 |
Why?
|
| Reaction Time | 1 | 2012 | 170 | 0.100 |
Why?
|
| Sesquiterpenes | 1 | 2011 | 41 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 1506 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2012 | 137 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 682 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2014 | 483 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 226 | 0.100 |
Why?
|
| Nicotine | 1 | 1994 | 350 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 1174 | 0.090 |
Why?
|
| Picrotoxin | 2 | 2002 | 14 | 0.090 |
Why?
|
| Electrophysiology | 2 | 2009 | 160 | 0.090 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2010 | 5 | 0.090 |
Why?
|
| Basal Nucleus of Meynert | 1 | 2010 | 6 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 342 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2014 | 1692 | 0.090 |
Why?
|
| Sodium Channels | 2 | 2003 | 24 | 0.090 |
Why?
|
| Membrane Proteins | 3 | 2014 | 617 | 0.080 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 2006 | 75 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2020 | 954 | 0.080 |
Why?
|
| Tupaiidae | 1 | 2008 | 1 | 0.080 |
Why?
|
| Atropine | 1 | 2008 | 29 | 0.080 |
Why?
|
| Cholinergic Antagonists | 1 | 2008 | 17 | 0.080 |
Why?
|
| GABA Agents | 1 | 2008 | 18 | 0.080 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 84 | 0.080 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2008 | 57 | 0.080 |
Why?
|
| src-Family Kinases | 1 | 2008 | 91 | 0.080 |
Why?
|
| Receptors, Presynaptic | 1 | 2007 | 6 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2008 | 276 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2008 | 289 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 34 | 0.070 |
Why?
|
| Type C Phospholipases | 1 | 2007 | 67 | 0.070 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2006 | 9 | 0.070 |
Why?
|
| Depression | 1 | 2014 | 943 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 167 | 0.070 |
Why?
|
| Tetrodotoxin | 2 | 1997 | 26 | 0.070 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 1 | 2005 | 2 | 0.070 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2005 | 5 | 0.070 |
Why?
|
| Sympathetic Nervous System | 1 | 2006 | 81 | 0.070 |
Why?
|
| Dendrites | 2 | 1997 | 44 | 0.070 |
Why?
|
| Evoked Potentials | 2 | 1997 | 61 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 329 | 0.060 |
Why?
|
| Guanylate Kinases | 2 | 2014 | 8 | 0.060 |
Why?
|
| Disks Large Homolog 4 Protein | 2 | 2014 | 15 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 4848 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1745 | 0.060 |
Why?
|
| Methoxamine | 1 | 2003 | 3 | 0.060 |
Why?
|
| Prazosin | 1 | 2003 | 10 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 981 | 0.060 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2003 | 20 | 0.060 |
Why?
|
| Chick Embryo | 2 | 1994 | 379 | 0.060 |
Why?
|
| Neurophysiology | 1 | 2022 | 17 | 0.050 |
Why?
|
| Brain Mapping | 2 | 1997 | 532 | 0.050 |
Why?
|
| Cerebellum | 1 | 2003 | 103 | 0.050 |
Why?
|
| Taurine | 1 | 2002 | 51 | 0.050 |
Why?
|
| Receptor, PAR-2 | 1 | 2021 | 7 | 0.050 |
Why?
|
| Zinc | 1 | 2002 | 73 | 0.050 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 2021 | 8 | 0.050 |
Why?
|
| Longevity | 1 | 2022 | 60 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 56 | 0.050 |
Why?
|
| X-Rays | 1 | 2021 | 56 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 74 | 0.050 |
Why?
|
| alpha-Synuclein | 1 | 2020 | 28 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 61 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2020 | 351 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2020 | 17 | 0.050 |
Why?
|
| Probiotics | 1 | 2020 | 14 | 0.050 |
Why?
|
| Dietary Fiber | 1 | 2020 | 37 | 0.050 |
Why?
|
| Cell Death | 1 | 2021 | 329 | 0.040 |
Why?
|
| Hypoxia | 1 | 2021 | 169 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 326 | 0.040 |
Why?
|
| Synaptic Potentials | 1 | 2019 | 8 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 307 | 0.040 |
Why?
|
| beta-Arrestins | 1 | 2019 | 80 | 0.040 |
Why?
|
| Apolipoprotein E4 | 1 | 2019 | 31 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 652 | 0.040 |
Why?
|
| Oscillometry | 1 | 1998 | 5 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 331 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 79 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 317 | 0.040 |
Why?
|
| Dopamine | 1 | 2020 | 474 | 0.040 |
Why?
|
| Tubocurarine | 1 | 1997 | 3 | 0.040 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1997 | 35 | 0.040 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 1997 | 6 | 0.040 |
Why?
|
| Metoclopramide | 1 | 1997 | 21 | 0.040 |
Why?
|
| Serotonin Antagonists | 1 | 1997 | 31 | 0.040 |
Why?
|
| ARNTL Transcription Factors | 1 | 2017 | 6 | 0.040 |
Why?
|
| Receptors, Serotonin | 1 | 1997 | 74 | 0.040 |
Why?
|
| Transcriptome | 1 | 2019 | 164 | 0.040 |
Why?
|
| Serotonin | 1 | 1997 | 144 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 1997 | 31 | 0.040 |
Why?
|
| Tubulin | 1 | 2017 | 60 | 0.040 |
Why?
|
| Genotype | 1 | 2019 | 786 | 0.040 |
Why?
|
| Indoles | 1 | 1997 | 146 | 0.040 |
Why?
|
| Diet | 1 | 2020 | 514 | 0.030 |
Why?
|
| Glycoside Hydrolases | 1 | 2016 | 25 | 0.030 |
Why?
|
| Axons | 1 | 1997 | 139 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 770 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 1752 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 178 | 0.030 |
Why?
|
| Mitochondria | 1 | 2020 | 643 | 0.030 |
Why?
|
| GTP-Binding Proteins | 2 | 1993 | 231 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2334 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 102 | 0.030 |
Why?
|
| Pyridines | 1 | 2017 | 261 | 0.030 |
Why?
|
| Post-Synaptic Density | 1 | 2014 | 7 | 0.030 |
Why?
|
| Brain | 2 | 2016 | 2176 | 0.030 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2014 | 59 | 0.030 |
Why?
|
| Cycloserine | 1 | 2014 | 30 | 0.030 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 1 | 1994 | 2 | 0.030 |
Why?
|
| Bungarotoxins | 1 | 1994 | 3 | 0.030 |
Why?
|
| Exercise | 1 | 2020 | 658 | 0.030 |
Why?
|
| Nicotinic Antagonists | 1 | 1994 | 11 | 0.030 |
Why?
|
| Sodium Channel Blockers | 1 | 1994 | 23 | 0.030 |
Why?
|
| Ganglia, Parasympathetic | 1 | 1993 | 1 | 0.030 |
Why?
|
| Enkephalin, Leucine | 1 | 1993 | 4 | 0.030 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 1 | 1993 | 7 | 0.030 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1993 | 27 | 0.030 |
Why?
|
| Enkephalin, Methionine | 1 | 1993 | 20 | 0.030 |
Why?
|
| Reticular Formation | 1 | 1993 | 13 | 0.030 |
Why?
|
| Substance P | 1 | 1993 | 39 | 0.030 |
Why?
|
| Lithium Chloride | 1 | 2013 | 10 | 0.030 |
Why?
|
| Naloxone | 1 | 1993 | 56 | 0.030 |
Why?
|
| Enkephalins | 1 | 1993 | 89 | 0.030 |
Why?
|
| Receptors, Opioid, delta | 1 | 1993 | 37 | 0.030 |
Why?
|
| Receptors, Opioid, mu | 1 | 1993 | 70 | 0.030 |
Why?
|
| Chickens | 1 | 1993 | 232 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2012 | 8 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2012 | 13 | 0.030 |
Why?
|
| Azepines | 1 | 2012 | 15 | 0.030 |
Why?
|
| Methylation | 1 | 2012 | 56 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 52 | 0.030 |
Why?
|
| Farnesol | 1 | 2011 | 2 | 0.030 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2011 | 9 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 20 | 0.030 |
Why?
|
| Mevalonic Acid | 1 | 2011 | 27 | 0.030 |
Why?
|
| Receptors, Drug | 1 | 1991 | 31 | 0.020 |
Why?
|
| Diterpenes | 1 | 2011 | 42 | 0.020 |
Why?
|
| Quinazolines | 1 | 2012 | 70 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1993 | 1083 | 0.020 |
Why?
|
| Histones | 1 | 2012 | 111 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 1447 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2012 | 124 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 331 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 223 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1991 | 109 | 0.020 |
Why?
|
| Polymers | 1 | 2012 | 244 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1040 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 1213 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 306 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5731 | 0.020 |
Why?
|
| Cues | 1 | 2012 | 654 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 2003 | 8 | 0.010 |
Why?
|
| Syntaxin 1 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Acid Sensing Ion Channels | 1 | 2003 | 3 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2003 | 18 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2003 | 71 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 95 | 0.010 |
Why?
|
| Synaptosomes | 1 | 2003 | 57 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 337 | 0.010 |
Why?
|
| Receptors, Cannabinoid | 1 | 1991 | 26 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1991 | 53 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1991 | 852 | 0.010 |
Why?
|